RJM Group, LLC | Detailed Evidence-Based Investigations

Dr. Ronald J Moleski peacefully passed away February 5, 2012 in CT Hospice, Branford. Dr. Moleski was a graduate of UCONN Pharmacy School and earned his Clinical Doctorate from the Philadelphia School of Science and Pharmacy. As one of the three founding partners of RJM Group, and over the past 14 years, Ron was instrumental in helping to build RJM into what it is today. He will be greatly missed. More...

Detailed Evidence-Based Investigations

Clinical outcome studies
Clinical outcomes studies involve comparative effectiveness analysis to better understand the outcome achieved with the course of therapy studied.

Time/motion studies
Time/motion studies identify the resources consumed (in time and money) both for the provider and the patient to help determine cost-effectiveness of care.

Financial and reimbursement analyses
Understanding the financial and reimbursement implications of drug therapy is important in the care process. And the impact of changing the approach to care must consider the financial and reimbursement implications of such a change.

Quality of life studies
Understanding the quality of life implications in the care process is an important care process differentiator.

Pharmaceutical pre- and post-market research
RJM provides pre and post market research to help better position and differentiate the product.